XML 31 R18.htm IDEA: XBRL DOCUMENT

Income Taxes	9 Months Ended
Oct. 03, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Note 10 – Income Taxes The effective income tax rate was 21.8% and 84.2% for the 12 weeks ended October 3, 2020 and October 5, 2019, respectively. The effective income tax rate was 10.5% and 129.0% for the 40 weeks ended October 3, 2020 and October 5, 2019, respectively. The differences from the federal statutory rate in the current year were primarily the result of the Coronavirus Aid, Relief and Economic Security (“CARES”) Act and related tax planning in the 40-week period, as well as federal tax credits, partially offset by state taxes, limitations on the deductibility of executive compensation, and the impacts of stock-based compensation in both the 12- and 40-week periods. In the prior year, the difference from the federal statutory rate was primarily due to state tax benefits as well as tax credits. On March 27, 2020, the U.S. government enacted tax legislation to provide economic stimulus and support businesses and individuals during the COVID-19 pandemic, referred to as the CARES Act. In connection with the CARES Act, the Company recorded net discrete income tax benefits of $9.3 million in 2020 associated with the additional deductibility of certain expenses combined with provisions which enable companies to carry back tax losses to years prior to the enactment of the Tax Cuts and Jobs Act (“Tax Reform”), where the federal statutory income tax rate was 35%.

Income Taxes

9 Months Ended

Oct. 03, 2020

Note 10 – Income Taxes

The effective income tax rate was 21.8% and 84.2% for the 12 weeks ended October 3, 2020 and October 5, 2019, respectively. The effective income tax rate was 10.5% and 129.0% for the 40 weeks ended October 3, 2020 and October 5, 2019, respectively. The differences from the federal statutory rate in the current year were primarily the result of the Coronavirus Aid, Relief and Economic Security (“CARES”) Act and related tax planning in the 40-week period, as well as federal tax credits, partially offset by state taxes, limitations on the deductibility of executive compensation, and the impacts of stock-based compensation in both the 12- and 40-week periods. In the prior year, the difference from the federal statutory rate was primarily due to state tax benefits as well as tax credits.

On March 27, 2020, the U.S. government enacted tax legislation to provide economic stimulus and support businesses and individuals during the COVID-19 pandemic, referred to as the CARES Act. In connection with the CARES Act, the Company recorded net discrete income tax benefits of $9.3 million in 2020 associated with the additional deductibility of certain expenses combined with provisions which enable companies to carry back tax losses to years prior to the enactment of the Tax Cuts and Jobs Act (“Tax Reform”), where the federal statutory income tax rate was 35%.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References + Details